Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07496450 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults

StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Enrollment closed, study ongoing
    • Enrollment target: estimated 4000 to confirmed 4050
    • Study sites: 36 to 35
    v3
  2. Site details revised at 33 of 36 sitesv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Moderna
49 trials monitored
See 3 trials at risk
The purpose of this study is to evaluate humoral immunogenicity after 2 doses of mRNA-1018-H5, and to evaluate the safety and reactogenicity of mRNA-1018-H5 in adults ≥18 years of age.
Trial Details
NCT Number NCT07496450
Lead Sponsor ModernaTX, Inc.
Conditions
(from sponsor)		 Influenza
Related terms Influenza in Birds, Influenza, Human, Virus Diseases
Enrollment 4,050 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov